Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism

Journal of Parenteral and Enteral Nutrition

Volumn 34, Issue 3, 2010, Pages 295-299

  Molfino, Alessio ^a   Cascino, Antonia ^a   Conte, Caterina ^a   Ramaccini, Cesarina ^a   Rossi Fanelli, Filippo ^a   Laviano, Alessandro ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Carnitine; Diabetes mellitus; Diet; Insulin resistance; Type 2

Indexed keywords

ANTIDIABETIC AGENT; CARNITINE; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; AGED; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DIET SUPPLEMENTATION; FEMALE; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LIFESTYLE MODIFICATION; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; BLOOD; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CALORIC RESTRICTION; CARNITINE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM DISORDERS; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 77953674236     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109353440     Document Type: Article

References (27)

1. Petersen KF, Befroy D., Dufour S., et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003 ; 300: 1140-1142.
2. Costell M., OgConnor JE, Grisolia S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun. 1989 ; 161: 1135-1143.
3. De Palo E., Gatti R., Sicolo N., Padovan D., Vettor R., Federspil G. Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetol Lat. 1981 ; 18: 91-95.
4. Tamamöullari N., Sili Y., Ià§äasiölu S., Atalay A. Carnitine deficiency in diabetes mellitus complications. J Diabetes Complications. 1999 ; 13: 251-253.
5. Stephens FB, Constantin-Teodosiu D., Greenhaff PL New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol. 2007 ; 581: 431-444.
6. Power RA, Hulver MW, Zhang JY, et al. Carnitine revisited: potential use as adjunctive treatment in diabetes. Diabetologia. 2007 ; 50: 824-832.
7. Derosa G., Cicero AF, Gaddi A., Mugellini A., Ciccarelli L., Fogari R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther. 2003 ; 25: 1429-1439.
8. De Gaetano A., Mingrone G., Castagneto M., Calvani M. Carnitine increases glucose disposal in humans. J Am Coll Nutr. 1999 ; 18: 289-295.
9. Mingrone G., Greco AV, Capristo E., et al. L-carnitine improves glucose disposal in type 2 diabetic patients. J Am Coll Nutr. 1999 ; 18: 77-82.
10. Rahbar AR, Shakerhosseini R., Saadat N., Taleban F., Pordal A., Gollestan B. Effect of L-carnitine on plasma glycemic and lipidemic profile in patients with type II diabetes mellitus. Eur J Clin Nutr. 2005 ; 59: 592-596.
11. Gonzalez-Ortiz M., Hernandez-Gonzalez SO, Hernandez-Salazar E., Martinez-Abundis E. Effect of oral 1-carnitine administration on insulin sensitivity and lipid profile in type 2 diabetes mellitus patients. Ann Nutr Metab. 2008 ; 52: 335-338.
12. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997 ; 20: 1183-1197.
13. Manco M., Calvani M., Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab. 2004 ; 6: 402-413.
14. Godarova A., Litzlbauer E., Brunner S., Agu AC, Lohninger A., Hofbauer R. L-carnitine regulates mRNA expression levels of the carnitine acyltransferase: CPT-1A, CPT-2, and CRAT. Chem Monthly. 2005 ; 136: 1349-1363.
15. Karlic H., Lohninger A., Laschan C., et al. Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromes. J Mol Med. 2003 ; 81: 435-442.
16. Ringseis R., Ludi S., Hirche F., Eder K. Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate increases carnitine absorption in rats. Pharmacol Res. 2008 ; 58: 58-64.
17. Rajasekar P., Anuradha CV Effect of L-carnitine on skeletal muscle lipids and oxidative stress in rats fed high-fructose diet. Exp Diabetes Res. 2007 ; 2007: 72741.
18. Rajasekar P., Viswanathan P., Anuradha CV Renoprotective action of L-carnitine in fructose-induced metabolic syndrome. Diabetes Obes Metab. 2008 ; 10: 171-180.
19. Malaguarnera M., Vacante M., Avitabile T., Malaguarnera M., Cammalleri L., Motta M. L-carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr. 2009 ; 89: 71-76.
20. Bruce CR, Thrush AB, Mertz VA, et al. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab. 2006 ; 291: E99 - E107.
21. Thyfault JP, Cree MG, Zheng D., et al. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am J Physiol Cell Physiol. 2007 ; 292: C729 - C739.
22. Heo YR, Kang CW, Cha YS L-carnitine changes the levels of insulin-like growth factors (IGFs) and IGF binding proteins in streprozotocininduced diabetic rats. J Nutr Sci Vitaminol (Tokyo). 2001 ; 47: 329-334.
23. Agudo J., Ayuso E., Jimenez V., et al. IGF-I mediates regeneration of endocrine pancreas by increasing beta cell replication through cell cycle protein modulation in mice. Diabetologia. 2008 ; 51: 1862-1872.
24. Minokoshi Y., Shiuchi T., Lee S., Suzuki A., Okamoto S. Role of hypothalamic AMP-kinase in food intake regulation. Nutrition. 2008 ; 24: 786-790.
25. Lopez M., Lage R., Saha AK, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab. 2008 ; 7: 389-399.
26. Bays HE, Gonzalez-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther. 2008 ; 6: 343-368.
27. Luci S., Hirche F., Eder K. Fasting and caloric restriction increases mRNA concentrations of novel organic cation transporter-2 and carnitine concentrations in rat tissues. Ann Nutr Metab. 2008 ; 52: 58-67.